Literature DB >> 21428731

Prevalence of major depression in ALS: comparison of a semi-structured interview and four self-report measures.

Panagiotis Ferentinos1, Thomas Paparrigopoulos, Michael Rentzos, Vassiliki Zouvelou, Theodoros Alexakis, Ioannis Evdokimidis.   

Abstract

This study aimed to compare prevalence estimates of current major depression obtained with a semi-structured interview and four frequently used self-report depression severity measures in a sample of amyotrophic lateral sclerosis (ALS) patients. Thirty-seven ALS patients (56.8% males) aged 37-80 years (mean 62.0 ± 10.7) without respiratory insufficiency or dementia were studied during hospitalization or on a follow-up visit. SCID-IV interview as well as self-report Hospital Anxiety and Depression Scale (HADS), ALS Depression Inventory (ADI), Center for Epidemiological Studies-Depression scale (CES-D) and Beck Depression Inventory (BDI-I) were administered. Kappa coefficients of diagnostic agreement between various instruments were calculated. Results showed that 37.8% of patients had a lifetime diagnosis of depression and in 13.5% depression followed ALS onset. Percentages of patients 'diagnosed' with current major depression were: 21.6% (SCID-IV), 16.7% (HADS-D ≥ 11), 16.2% (ADI ≥ 29), 25% (CES-D ≥ 24) and 24.3% (BDI-I ≥ 16). High kappa values were recorded between CES-D, BDI-I and SCID-IV as well as between HADS-D and ADI. CES-D, BDI-I and SCID-IV gave the highest prevalence estimates of current major depression in ALS patients and were in poor agreement with estimates based on HADS and ADI; it is suggested that this is possibly because the former give a far greater emphasis on physical symptoms of depression than the latter.

Entities:  

Mesh:

Year:  2011        PMID: 21428731     DOI: 10.3109/17482968.2011.556744

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  14 in total

1.  Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study.

Authors:  A Pizzimenti; M Aragona; E Onesti; M Inghilleri
Journal:  Funct Neurol       Date:  2013 Apr-May

Review 2.  Comorbidities in Neurology: Is adenosine the common link?

Authors:  Detlev Boison; Eleonora Aronica
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

3.  Association between depression and survival in Chinese amyotrophic lateral sclerosis patients.

Authors:  Qianqian Wei; Zhenzhen Zheng; Xiaoyan Guo; Ruwei Ou; Xueping Chen; Rui Huang; Jing Yang; Huifang Shang
Journal:  Neurol Sci       Date:  2016-01-13       Impact factor: 3.307

4.  Serum agrin and talin are increased in major depression while agrin and creatine phosphokinase are associated with chronic fatigue and fibromyalgia symptoms in depression.

Authors:  Hussein Kadhem Al-Hakeim; Ameer Abdul Razzaq Al-Issa; Michael Maes
Journal:  Metab Brain Dis       Date:  2019-11-16       Impact factor: 3.584

5.  Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease.

Authors:  Chris J Gibbons; Roger J Mills; Everard W Thornton; John Ealing; John D Mitchell; Pamela J Shaw; Kevin Talbot; Alan Tennant; Carolyn A Young
Journal:  Health Qual Life Outcomes       Date:  2011-09-29       Impact factor: 3.186

6.  Formal psychological assessment in evaluating depression: a new methodology to build exhaustive and irredundant adaptive questionnaires.

Authors:  Francesca Serra; Andrea Spoto; Marta Ghisi; Giulio Vidotto
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

7.  Communication of diagnosis in amyotrophic lateral sclerosis: stratification of patients for the estimation of the individual needs.

Authors:  Alessia Pizzimenti; Maria Cristina Gori; Emanuela Onesti; Bev John; Maurizio Inghilleri
Journal:  Front Psychol       Date:  2015-06-02

8.  Interaction of physical function, quality of life and depression in Amyotrophic lateral sclerosis: characterization of a large patient cohort.

Authors:  Sonja Körner; Katja Kollewe; Susanne Abdulla; Antonia Zapf; Reinhard Dengler; Susanne Petri
Journal:  BMC Neurol       Date:  2015-05-16       Impact factor: 2.474

9.  Arterial Hypertension and Health-Related Quality of Life.

Authors:  Vasiliki Katsi; Manolis S Kallistratos; Konstantinos Kontoangelos; Pavlos Sakkas; Kyriakos Souliotis; Costas Tsioufis; Petros Nihoyannopoulos; George N Papadimitriou; Dimitris Tousoulis
Journal:  Front Psychiatry       Date:  2017-12-04       Impact factor: 4.157

10.  Psychosocial adjustment to ALS: a longitudinal study.

Authors:  Tamara Matuz; Niels Birbaumer; Martin Hautzinger; Andrea Kübler
Journal:  Front Psychol       Date:  2015-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.